New research is drawing attention to a possible association between estrogen-only hormone therapy during menopause and a lower risk of dementia in women, while also highlighting the need for further research before the findings can be translated into treatment recommendations.
The study, published in the scientific journal Neurology, examined medical data from 21,462 women, including 1,953 who had received estrogen-only hormone therapy.
Researchers also had access to biomarker results, brain imaging and autopsy data from some participants, allowing them to investigate biological changes associated with Alzheimer’s disease, including the accumulation of amyloid plaques and tau protein.
Estrogen Use Linked to Lower Dementia Risk
The researchers found that women who had received estrogen-only hormone therapy were 39% less likely to have a dementia diagnosis compared with women who had not received the therapy.
The analysis also found that women who had used estrogen were 35% less likely to show pathological changes associated with Alzheimer’s disease.
The researchers adjusted the analysis for several factors that could influence the results, including age, education and genetic factors.
Blood and cerebrospinal fluid analyses also indicated lower levels of amyloid accumulation among women who had received estrogen therapy.
What the Findings Could Mean for Women’s Brain Health
The findings add to ongoing scientific interest in the relationship between estrogen and brain health during and after menopause.
Estrogen has long been studied for its potential effects on neurological processes, including mechanisms associated with Alzheimer’s disease. However, evidence from previous research has not produced a clear consensus on whether hormone therapy can prevent dementia or Alzheimer’s disease. (JAMA Network)
Some studies have reported potential benefits, while randomized clinical trials involving older postmenopausal women have raised concerns about dementia risk with certain hormone therapy regimens, particularly combined estrogen-progestogen therapy. (PubMed)
This makes the distinction between an observed association and a proven protective effect particularly important.
Researchers Warn Against Viewing Estrogen as a Dementia Prevention Treatment
Despite the promising findings, researchers emphasized that the study does not establish that estrogen therapy prevents dementia or protects women from Alzheimer’s disease.
The results demonstrate a statistical association between estrogen use and the outcomes observed in the study. They do not prove that estrogen itself was responsible for the lower dementia risk or reduced Alzheimer’s-related changes.
This distinction is especially important because hormone therapy can have different effects depending on factors such as the type of treatment, a woman’s age, timing of treatment and individual health circumstances.
Previous research has produced mixed findings, and some large studies have associated certain forms of menopausal hormone therapy with increased dementia risk. (BMJ)
Why More Research on Women’s Brain Health Matters
The findings add another piece to a complex area of research into menopause, hormones and women’s neurological health.
Understanding how hormonal changes during menopause may interact with brain aging could eventually help researchers identify more effective approaches to protecting cognitive health in women.
For now, however, the study should be viewed as evidence that warrants further investigation rather than as a recommendation for estrogen therapy as a strategy to prevent dementia.
Women considering hormone therapy should discuss its potential benefits and risks with a qualified healthcare professional based on their individual medical history, age, symptoms and treatment goals.
